|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amrutkar M and Gladhaug I: Pancreatic
cancer chemoresistance to gemcitabine. Cancers. 9:1572017.
View Article : Google Scholar :
|
|
3
|
Du B and Shim JS: Targeting
Epithelial-mesenchymal transition (EMT) to overcome drug resistance
in cancer. Molecules. 21(pii): E9652016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arumugam T, Ramachandran V, Fournier KF,
Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey
DJ and Choi W: Epithelial to mesenchymal transition contributes to
drug resistance in pancreatic cancer. Cancer Res. 69:5820–5828.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bronsert P, Enderle-Ammour K, Bader M,
Timme S, Kuehs M, Csanadi A, Kayser G, Kohler I, Bausch D, Hoeppner
J, et al: Cancer cell invasion and EMT marker expression: A
three-dimensional study of the human cancer-host interface. J
Pathol. 234:410–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang L, Wu H, Wang L, Zhang H, Lu J, Liang
Z and Liu T: Asporin promotes pancreatic cancer cell invasion and
migration by regulating the epithelial-to-mesenchymal transition
(EMT) through both autocrine and paracrine mechanisms. Cancer Lett.
398:24–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK,
Vonderheide RH, et al: EMT and dissemination precede pancreatic
tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fischer KR, Durrans A, Lee S, Sheng J, Li
F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al:
Epithelial-to-mesenchymal transition is not required for lung
metastasis but contributes to chemoresistance. Nature. 527:472–476.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng X, Carstens JL, Kim J, Scheible M,
Kaye J, Sugimoto H, Wu CC, LeBleu VS and Kalluri R:
Epithelial-to-mesenchymal transition is dispensable for metastasis
but induces chemoresistance in pancreatic cancer. Nature.
527:525–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
So WK, Fan Q, Lau MT, Qiu X, Cheng JC and
Leung PC: Amphiregulin induces human ovarian cancer cell invasion
by down-regulating E-cadherin expression. FEBS Lett. 588:3998–4007.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Willmarth NE and Ethier SP: Autocrine and
juxtacrine effects of amphiregulin on the proliferative, invasive,
and migratory properties of normal and neoplastic human mammary
epithelial cells. J Biol Chem. 281:37728–37737. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thøgersen VB, Sorensen BS, Poulsen SS,
Orntoft TF, Wolf H and Nexø E: A subclass of HER1 ligands is a
prognostic marker for survival in bladder cancer patients. Cancer
Res. 61:6227–6233. 2001.PubMed/NCBI
|
|
13
|
Ishikawa N, Daigo Y, Takano A, Taniwaki M,
Kato T, Hayama S, Murakami H, Takeshima Y, Inai K, Nishimura H, et
al: Increases of amphiregulin and transforming growth factor-alpha
in serum as predictors of poor response to gefitinib among patients
with advanced non-small cell lung cancers. Cancer Res.
65:9176–9184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jing C, Jin YH, You Z, Qiong Q and Jun Z:
Prognostic value of amphiregulin and epiregulin mRNA expression in
metastatic colorectal cancer patients. Oncotarget. 7:55890–55899.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shinomiya H, Ito Y, Kubo M, Yonezawa K,
Otsuki N, Iwae S, Inagaki H and Nibu KI: Expression of amphiregulin
in mucoepidermoid carcinoma of the major salivary glands: A
molecular and clinicopathological study. Hum Pathol. 57:37–44.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Wu H, Wang L, Lu J, Duan H, Liu X
and Liang Z: Expression of amphiregulin predicts poor outcome in
patients with pancreatic ductal adenocarcinoma. Diagn Pathol.
11:602016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang H, Wu H, Guan J, Wang L, Ren X, Shi
X, Liang Z and Liu T: Paracrine SDF-1α signaling mediates the
effects of PSCs on GEM chemoresistance through an IL-6 autocrine
loop in pancreatic cancer cells. Oncotarget. 6:3085–3097.
2015.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao S, Sun Y, Zhang X, Hu L, Liu Y, Chua
CY, Phillips LM, Ren H, Fleming JB, Wang H, et al: IGFBP2 Activates
the NF-κB pathway to drive epithelial-mesenchymal transition and
invasive character in pancreatic ductal adenocarcinoma. Cancer Res.
76:6543–6554. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nomura A, Majumder K, Giri B, Dauer P,
Dudeja V, Roy S, Banerjee S and Saluja AK: Inhibition of NF-kappa B
pathway leads to deregulation of epithelial-mesenchymal transition
and neural invasion in pancreatic cancer. Lab Invest. 96:1268–1278.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Busser B, Sancey L, Brambilla E, Coll JL
and Hurbin A: The multiple roles of amphiregulin in human cancer.
Biochim Biophys Acta. 1816:119–131. 2011.PubMed/NCBI
|
|
23
|
Liu JF, Tsao YT and Hou CH: Amphiregulin
enhances intercellular adhesion molecule-1 expression and promotes
tumor metastasis in human osteosarcoma. Oncotarget. 6:40880–40895.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chung E, Cook PW, Parkos CA, Park YK,
Pittelkow MR and Coffey RJ: Amphiregulin causes functional
downregulation of adherens junctions in psoriasis. J Invest
Dermatol. 124:1134–1140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Coradini D, Casarsa C and Oriana S:
Epithelial cell polarity and tumorigenesis: New perspectives for
cancer detection and treatment. Acta Pharmacol Sin. 32:552–564.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kleeff J, Shi X, Bode HP, Hoover K,
Shrikhande S, Bryant PJ, Korc M, Büchler MW and Friess H: Altered
expression and localization of the tight junction protein ZO-1 in
primary and metastatic pancreatic cancer. Pancreas. 23:259–265.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guaita S, Puig I, Francı́ C, Garrido M,
Dominguez D, Batlle E, Sancho E, Dedhar S, De Herreros AG and
Baulida J: Snail induction of epithelial to mesenchymal transition
in tumor cells is accompanied by MUC1 repression and ZEB1
expression. J Biol Chem. 277:39209–39216. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang HW, Menon LG, Black PM, Carroll RS
and Johnson MD: SNAI2/Slug promotes growth and invasion in human
gliomas. BMC Cancer. 10:3012010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang C, Wang Z, Li YY, Yu BH, Zhang F and
Li HY: miR-33a suppresses the nuclear translocation of β-catenin to
enhance gemcitabine sensitivity in human pancreatic cancer cells.
Tumor Biol. 36:9395–9403. 2015. View Article : Google Scholar
|
|
32
|
von Ahrens D, Bhagat TD, Nagrath D, Maitra
A and Verma A: The role of stromal cancer-associated fibroblasts in
pancreatic cancer. J Hematol Oncol. 10:762017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duner S, Lopatko LJ, Ansari D, Gundewar C
and Andersson R: Pancreatic cancer: The role of pancreatic stellate
cells in tumor progression. Pancreatology. 10:673–681. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vonlaufen A, Joshi S, Qu C, Phillips PA,
Xu Z, Parker NR, Toi CS, Pirola RC, Wilson JS, Goldstein D and Apte
MV: Pancreatic stellate cells: Partners in crime with pancreatic
cancer cells. Cancer Res. 68:2085–2093. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kikuta K, Masamune A, Watanabe T, Ariga H,
Itoh H, Hamada S, Satoh K, Egawa S, Unno M and Shimosegawa T:
Pancreatic stellate cells promote epithelial-mesenchymal transition
in pancreatic cancer cells. Biochem Biophys Res Commun.
403:380–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Saito K, Sakaguchi M, Maruyama S, Iioka H,
Putranto EW, Sumardika IW, Tomonobu N, Kawasaki T, Homma K and
Kondo E: Stromal mesenchymal stem cells facilitate pancreatic
cancer progression by regulating specific secretory molecules
through mutual cellular interaction. J Cancer. 9:2916–2929. 2018.
View Article : Google Scholar : PubMed/NCBI
|
